Physician profile
Heidi Lynn Yip
NPI 1952941494
$28,827.99
in general payments reported to CMS, 2019-2025
46 companies · $16K in 2025
The $16K reported for 2025 was more than what 99% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,472 · 2022: $3,831 · 2023: $1,036 · 2024: $5,559 · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Food and Beverage: $5,569 · Consulting Fee: $4,143 · Travel and Lodging: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,473.75 |
| Food and Beverage | $5,568.82 |
| Consulting Fee | $4,142.50 |
| Travel and Lodging | $1,339.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $19,531.24 | 2021-2025 | |
| Pfizer INC. | $2,973.11 | 2023-2025 | |
| Livanova USA, INC. | $1,521.28 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Teva Pharmaceuticals USA, INC. | $731.05 | 2021-2025 | Ajovy, Austedo Xr, Austedo Xr |
| Biogen, INC. | $376.94 | 2021-2022 | |
| Lundbeck LLC | $352.16 | 2021-2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $314.07 | 2022 | |
| Genzyme Corporation | $266.91 | 2021-2022 | |
| Amgen INC. | $241.79 | 2021-2023 | Aimovig |
| Acadia Pharmaceuticals INC | $220.73 | 2021-2023 | Nuplazid |
| Lilly USA, LLC | $211.93 | 2021-2024 | Reyvow, Emgality |
| Biohaven Pharmaceuticals, INC. | $191.86 | 2021 | |
| Neurelis, INC. | $159.21 | 2021-2022 | |
| Axsome Therapeutics, INC. | $158.89 | 2025 | Symbravo |
| Amneal Pharmaceuticals LLC | $136.27 | 2021-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Yip listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.